Akebia Therapeutics to Conduct Investor Meetings at the Virtual U.S. Bancorp I BTIG Kidney Health Forum
Globe Newswire•07/10/2026•08:00 ET
0
Key Highlights
- ➤Akebia executives will hold one-on-one investor meetings October 14, 2026
- ➤Management will discuss commercial products and clinical-stage rare kidney disease pipeline assets
WALTHAM, Mass., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics(®) (link), Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John P. Butler, Chief Executive Officer, Dr. Steven Burke, Chief R&D and Medical Officer, and Erik Ostrowski, Chief Financial and Chief Business Officer, will participate in one-on-one meetings at the Virtual U.S. Bancorp I BTIG Kidney Health Forum on October 14, 2026.
During meetings, management will discuss its commercial products and clinical stage, differentiated pipeline assets for rare kidney diseases.
Get started
Create a free account to read the full story.